Disease resurgence, production capability issues and safety concerns in the context of an aging population: Is there a need for a new yellow fever vaccine?

14Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine. This trend has increased the level of concern about the disease and the potential for importation to areas in Asia with ecological conditions that can sustain yellow fever virus transmission. In this article, we provide a broad overview of yellow fever burden of disease, natural history, treatment, vaccine, prevention and control initiatives, and vaccine and therapeutic agent development efforts.

Cite

CITATION STYLE

APA

Tomashek, K. M., Challberg, M., Nayak, S. U., & Schiltz, H. F. (2019, December 1). Disease resurgence, production capability issues and safety concerns in the context of an aging population: Is there a need for a new yellow fever vaccine? Vaccines. MDPI AG. https://doi.org/10.3390/vaccines7040179

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free